Literature DB >> 24054333

Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis.

A F Schmidt1, M Nielen, O H Klungel, A W Hoes, A de Boer, R H H Groenwold, J Kirpensteijn.   

Abstract

Recently an aggregated data meta-analysis showed that serum alkaline phosphatase (SALP) and proximal humerus location are predictors for shorter survival in canine osteosarcoma. To identify additional prognostic factors of mortality and metastasis an individual patient data meta-analysis (IPDMA) was conducted. Individual patient data from 20 studies, identified via the VSSO society, were pooled. Univariable and multivariable hazard ratios (HR) for metastasis and mortality were assessed, using stratified Cox models. The study included 1405 dogs who received surgical treatment, of which the metastasis status was measured in 1155 dogs and mortality status in 1336 dogs; median survival was 256 days. High versus normal SALP and weight (kg) were associated with an increase in hazard of metastasis [HR 1.34 (95%CI 1.07; 1.68) and HR 1.02 (per kg increase) (95%CI 1.01; 1.03)] and for mortality [HR 1.43 (95%CI 1.16; 1.77) and HR 1.02 (95%CI 1.01; 1.02)]. Distal radius tumor was associated with a lower hazard of metastasis compared to other locations: HR 0.75 (95%CI 0.58; 0.96). Proximal humerus and distal femur or proximal tibia location were related with an increased mortality: HR 1.53 (95%CI 1.26; 1.84) and HR 1.23 (95%CI 1.01; 1.49) compared to other locations. Older age (years) was associated with a higher hazard for mortality [HR 1.06 per year (95%CI 1.03; 1.09)] but not for metastasis: HR 1.03 (95%CI 0.99; 1.06). These results confirm findings from a recent aggregated data meta-analysis and (in addition) showed that tumor location, SALP, weight were prognostic factors for both mortality and metastasis. Age was a prognostic factor for mortality but not for metastasis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Canine; Disease free survival; Oncology; Risk factors; Survival

Mesh:

Substances:

Year:  2013        PMID: 24054333     DOI: 10.1016/j.prevetmed.2013.08.011

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  11 in total

1.  Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010-2019).

Authors:  Beck Ringdahl-Mayland; Douglas H Thamm; Tiffany W Martin
Journal:  Front Vet Sci       Date:  2022-05-10

2.  Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns.

Authors:  L C de Sá Rodrigues; K E Holmes; V Thompson; C M Piskun; S E Lana; M A Newton; T J Stein
Journal:  Vet Comp Oncol       Date:  2015-02-03       Impact factor: 2.613

3.  Osteocytes serve as a progenitor cell of osteosarcoma.

Authors:  Joseph L Sottnik; Brittany Campbell; Rohit Mehra; Omid Behbahani-Nejad; Christopher L Hall; Evan T Keller
Journal:  J Cell Biochem       Date:  2014-08       Impact factor: 4.429

4.  Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.

Authors:  Cheryl A London; Heather L Gardner; Tamra Mathie; Nicole Stingle; Roberta Portela; Michael L Pennell; Craig A Clifford; Mona P Rosenberg; David M Vail; Laurel E Williams; Kim L Cronin; Heather Wilson-Robles; Antonella Borgatti; Carolyn J Henry; Dennis B Bailey; Jennifer Locke; Nicole C Northrup; Martin Crawford-Jakubiak; Virginia L Gill; Mary K Klein; David M Ruslander; Doug H Thamm; Brenda Phillips; Gerald Post
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

Review 5.  What do we know about canine osteosarcoma treatment? Review.

Authors:  M Szewczyk; R Lechowski; K Zabielska
Journal:  Vet Res Commun       Date:  2014-11-26       Impact factor: 2.459

6.  An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.

Authors:  Anita K Luu; Courtney R Schott; Robert Jones; Andrew C Poon; Brandon Golding; Roa'a Hamed; Benjamin Deheshi; Anthony Mutsaers; Geoffrey A Wood; Alicia M Viloria-Petit
Journal:  BMC Vet Res       Date:  2018-11-26       Impact factor: 2.741

7.  Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma.

Authors:  Federica Riccardo; Lidia Tarone; Selina Iussich; Davide Giacobino; Maddalena Arigoni; Federica Sammartano; Emanuela Morello; Marina Martano; Francesca Gattino; Raffaella De Maria; Soldano Ferrone; Paolo Buracco; Federica Cavallo
Journal:  Ther Adv Med Oncol       Date:  2019-06-06       Impact factor: 8.168

8.  The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells.

Authors:  Courtney R Schott; Latasha Ludwig; Anthony J Mutsaers; Robert A Foster; Geoffrey A Wood
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

9.  Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.

Authors:  Kazuki Heishima; Travis Meuten; Kyoko Yoshida; Takashi Mori; Douglas H Thamm
Journal:  BMC Vet Res       Date:  2019-01-25       Impact factor: 2.741

10.  Genetic Variant of NFIB is Associated With the Metastasis of Osteosarcoma in Chinese Population.

Authors:  Leilei Xu; Jun Ni; Yongjie Wang; Yang Dong; Shoufeng Wang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.